Thirty years after Dolly the sheep becomes the first cloned mammal in 1996, cloning technology has advanced but does not function as a simple “copy-and-paste” method for making living animals. The experience from Dolly and subsequent work shows that cloning is scientifically achievable, yet biologically inefficient and highly sensitive to conditions such as the health and development of embryos, the techniques used, and the suitability of the starting cells.
Multiple outlets note that early public expectations—including widespread cloned pets, cloning of humans, and the resurrection of extinct species—have not materialized. Instead, cloning is now better understood as a tool that supports specific research and applications, while its limitations remain substantial. The science has contributed to progress in related areas of biology, including understanding how cells develop and how genetic material is reprogrammed during development. Overall, cloning is viewed less as a ready-made consumer technology and more as a complex laboratory process, with ongoing research focused on improving success rates and reducing developmental problems.
